Abstract: The present invention relates to a series of new N-acylated 4-hydroxyphenylamine derivatives, linked via an alkylene bridge to the nitrogen atom of a 1,2-benzisothiazol-3(2H)-one 1,1-dioxide group of formula I: ##STR1## in which n is a number from 1 to 5, and to processes for preparing these derivatives and to pharmaceutical compositions containing said derivatives; these compounds possess high analgesic activity free from antipyretic activity, and they display little hepatotoxic effect.
Type:
Grant
Filed:
September 18, 1995
Date of Patent:
April 15, 1997
Assignee:
LSU Medical Center Foundation
Inventors:
Nicolas G. Bazan, Julio Alvarez-Builla Gomez
Abstract: The present invention relates to a series of new N-acylated 4-hydroxyphenylamine derivatives, linked via an alkylene bridge to the nitrogen atom of a 1,2-benzisothiazol-3(2H)-one 1,1-dioxide group, of formula I: ##STR1## in which n is a number from 1 to 5, and to processes for preparing these derivatives and to pharmaceutical compositions containing said derivatives; these compounds possess high analgesic activity free from antipyretic activity, and they display little hepatotoxic effect.
Type:
Grant
Filed:
April 21, 1995
Date of Patent:
September 10, 1996
Assignee:
LSU Medical Center Foundation
Inventors:
Nicolas G. Bazan, Julio Alvarez-Builla Gomez